Abbott Laboratories ABT
101.29
0.22
0.22%
as of 25 Sep
- Market cap
- $174.8B
- P/E
- 32.8×
Follow ABT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Abbott Laboratories (ABT) P/S ratio
As of 25 September 2026, Abbott Laboratories (ABT) trades at a P/S ratio of 3.8×. Over the past ten years it has ranged from 2.7× (February 2016) to 6.6× (February 2021); the current reading is higher than 29% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 4.9× | 4.89% |
| FY2024 | 4.7× | (1.55%) |
| FY2023 | 4.8× | 8.29% |
| FY2022 | 4.4× | (24.12%) |
| FY2021 | 5.8× | 3.39% |
| FY2020 | 5.6× | 16.53% |
| FY2019 | 4.8× | 15.75% |
| FY2018 | 4.2× | 11.34% |
| FY2017 | 3.7× | 35.03% |
| FY2016 | 2.8× | (16.00%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 3.4× | (14.47%) |
| Mar 2026 | 4.0× | (19.45%) |
| Dec 2025 | 4.9× | (7.54%) |
| Sep 2025 | 5.3× | (3.24%) |
| 42 more quarters | Free account |
Against its own ten years
Low 2.7×
High 6.6×
Ten-year median
4.4×
Current reading's percentile
29
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.2× |
| GEHC GE HealthCare Technologies Inc. compare | 1.4× |
| MDT Medtronic PLC compare | 3.0× |
| BSX Boston Scientific Corporation compare | 3.1× |
| STE STERIS plc compare | 3.4× |
| ABT Abbott Laboratories | 3.8× |
| SYK Stryker Corporation compare | 4.0× |
| DXCM DexCom, Inc. compare | 6.7× |
| EW Edwards Lifesciences Corporation compare | 7.6× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ABT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement